Serum albumin levels in ischemic stroke and its subtypes: Correlation with clinical outcome

Nutrition

Volumn 29, Issue 6, 2013, Pages 872-875

  Babu, Mallemoggala Sai ^a,b   Kaul, Subhash ^c   Dadheech, Sneha ^a   Rajeshwar, Koppula ^a,b   Jyothy, Akka ^a   Munshi, Anjana ^a  

^a OSMANIA UNIVERSITY   (India)

^b Dr NTR University of Health Sciences   (India)

^c NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Albumin; Ischemic stroke; Poor outcome; Stroke subtypes

Indexed keywords

CHOLESTEROL; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; RECURRENCE; RISK FACTORS; SERUM ALBUMIN; STROKE; TREATMENT OUTCOME;

ANIMALIA;

EID: 84877624139     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.12.015     Document Type: Article

References (41)

1. Phillips A., Shaper A.G., Winchup P.H. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989, 2:1434-1436.
2. Shibata H., Haga H., Ueno M., Nagai H., Yasumura S., Koyano W. Longitudinal changes of serum in elderly people living in the community. Age Ageing 1991, 20:417-420.
3. Herrmann F.C., Safran C., Levkoff S.E., Minaker K.L. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992, 152:125-130.
4. Agarwal N., Acevedo F., Leighton L.S., Cayten C.G., Pitchumoni C.S. Predictive ability of various nutritional variables for mortality in elderly people. Am J Clin Nutr 1988, 48:1173-1178.
5. Corti M.C., Guralnik J.M., Salive M.E., Sorkin J.D. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994, 272:1036-1042.
6. Aptaker R.L., Roth E.J., Reichardt G., Duerden M.E., Levy C.E. Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil 1994, 75:80-84.
7. Djousse L., Rothman K.J., Cupples L.A., Levy D., Ellison R.C. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002, 106:2919-2924.
8. Høstmark A.T. Serum albumin and prevalence of coronary heart disease: a population-based, cross-sectional study. Nor J Epidemiol 2003, 13:107-113.
9. Høstmark A.T., Tomten S.E. Serum albumin and prevalence of stroke: a population-based, cross-sectional study. Eur J CardiovascPrevRehabil 2006, 13:87-90.
10. Ginsberg M.D., Palesch Y.Y., Martin R.H., Hill M.D., Moy C.S., Waldman B.D., et al. The Albumin in Acute Stroke (ALIAS) Multicenter Clinical Trial. Safety analysis of part 1 and rationale and design of part 2. Stroke 2011, 42:119-127.
11. Hill M.D., Martin R.H., Palesch Y.Y., Tamariz D., Waldman B., Ryckborst K.J., et al. The Albumin in Acute Stroke Part 1 Trial. An exploratory efficacy analysis. Stroke 2011, 42:1621-1625.
12. Dziedzic T., Slowik A., Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004, 35:e156-e158.
13. Munshi A., Shehnaz S., Kaul S., Reddy B.P., Alladi S., Jyothy A. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. J Neurol Sci 2008, 272:132-135.
14. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24(1):35-41.
15. Belayev L., Liu Y., Zhao W., Busto R., Ginsberg M.D. Human albumin therapy of acute ischemic stroke. Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001, 32:553-560.
16. Sulter G., Steen C., De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999, 30:1538-1541.
17. Alvarez-Perez F.J., Castelo-Branco M., Alvarez-Sabin J. Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology. Int J Neurosci 2011, 121:25-32.
18. Belayev L., Busto R., Zhao W., Clemens J.A., Ginsberg M.D. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg 1997, 87:595-601.
19. Belayev L., Zhao W., Pattany P.M., Weaver R.G., Huh P.W., Lin B., et al. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke 1998, 29:2587-2599.
20. Aptaker R.L., Roth E.J., Reichhardt G., Duerden M.E., Levy C.E. Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil 1994, 75(1):80-84.
21. Lee M., Saver J.L., Chang K.H., Ovbiagele B. Level of albuminuria and risk of stroke: systematic review and meta-analysis. Cerebrovasc Dis 2010, 30:464-469.
22. Halliwell B. Albumin: an important extracellular antioxidant?. Biochem Pharm 1988, 37:569-571.
23. Maalej N., Albrecht R., Loscalzo J., Folts J.D. The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol 1999, 33:1408-1414.
24. Gresele P., Deckmyn H., Huybrechts E., Vermylen J. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol 1984, 33:2083-2088.
25. Jorgensen K.A., Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res 1980, 17:13-18.
26. Schnitzer J.E., Oh P. Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium. Am J Physiol 1992, 263:H1872-H1879.
27. Reinhart W.H., Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995, 25:523-528.
28. Halliwell B., Gutteridge J.M. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990, 280:1-8.
29. Nadal A., Fuentes E., Pastor J., McNaughton P.A. Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes. Proc Natl Acad Sci U S A 1995, 92:1426-1430.
30. Tabernero A., Medina A., Sanchez-Abarca L.I., Lavado E., Medina J.M. The effect of albumin on astrocyte energy metabolism is not brought about through the control of cytosolic Ca2+ concentrations but by free-fatty acid sequestration. Glia 1999, 25:1-9.
31. Bogaert Y.E., Rosenthal R.E., Fiskum G. Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. Free Radic Biol Med 1994, 16:811-820.
32. Huh P.W., Belayev L., Zhao W., Busto R., Saul I., Ginsberg M.D. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res 1998, 804:105-113.
33. Remmers M., Schmidt-Kastner R., Belayev L., Lin B., Busto R., Ginsberg M.D. Protein extravasation and cellular uptake after high-dose human-albumin treatment of transient focal cerebral ischemia in rats. Brain Res 1999, 827:237-242.
34. Belayev L., Zhao W., Pattany P.M., Weaver R.G., Huh P.W., Lin B., et al. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke 1998, 29:2587-2599.
35. Marsh J.B. Lipoprotein metabolism in experimental nephrosis. Proc Soc Exp Biol Med 1996, 213:178-186.
36. Viswanathan V., Snehalatha C., Kumutha R., Jayaraman M., Ramachandran A. Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol 2004, 14:89-92.
37. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Schlager O., et al. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis-interrelation with traditional cardiovascular risk factors. Thromb Haemost 2004, 91:610-618.
38. Cooper B.A., Penne E.L., Bartlett L.H., Pollock C.A. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004, 43:61-66.
39. Gariballa S.E., Parker S.G., Taub N., Castleden Mark Nutritional status of hospitalized acute stroke patients. Brit J Nutr 1998, 79:481-487.
40. Van de Poel E., Hosseinpoor A.R., Jehu-Appiah C., Vega J., Speybroeck N. Malnutrition and the disproportional burden on the poor: the case of Ghana. Int J Equity Health 2007, 28:6-21.
41. Munshi A., Babu S., Kaul S., Shafi G., Rajeshwar K., Alladi S., Jyothy A. Depletion of Serum zinc in ischemic stroke patients. Methods Find Exp Clin Pharmacol 2010, 32:433-436.